BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 29018252)

  • 1. Neutralization of Zika virus by germline-like human monoclonal antibodies targeting cryptic epitopes on envelope domain III.
    Wu Y; Li S; Du L; Wang C; Zou P; Hong B; Yuan M; Ren X; Tai W; Kong Y; Zhou C; Lu L; Zhou X; Jiang S; Ying T
    Emerg Microbes Infect; 2017 Oct; 6(10):e89. PubMed ID: 29018252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for Zika envelope domain III recognition by a germline version of a recurrent neutralizing antibody.
    Esswein SR; Gristick HB; Jurado A; Peace A; Keeffe JR; Lee YE; Voll AV; Saeed M; Nussenzweig MC; Rice CM; Robbiani DF; MacDonald MR; Bjorkman PJ
    Proc Natl Acad Sci U S A; 2020 May; 117(18):9865-9875. PubMed ID: 32321830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of differential Zika and dengue virus neutralization by a public antibody lineage targeting the DIII lateral ridge.
    Zhao H; Xu L; Bombardi R; Nargi R; Deng Z; Errico JM; Nelson CA; Dowd KA; Pierson TC; Crowe JE; Diamond MS; Fremont DH
    J Exp Med; 2020 Feb; 217(2):. PubMed ID: 31757867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Convalescent patient-derived monoclonal antibodies targeting different epitopes of E protein confer protection against Zika virus in a neonatal mouse model.
    Niu X; Zhao L; Qu L; Yao Z; Zhang F; Yan Q; Zhang S; Liang R; Chen P; Luo J; Xu W; Lv H; Liu X; Lei H; Yi C; Li P; Wang Q; Wang Y; Yu L; Zhang X; Bryan LA; Davidson E; Doranz JB; Feng L; Pan W; Zhang F; Chen L
    Emerg Microbes Infect; 2019; 8(1):749-759. PubMed ID: 31130109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus.
    Swanstrom JA; Plante JA; Plante KS; Young EF; McGowan E; Gallichotte EN; Widman DG; Heise MT; de Silva AM; Baric RS
    mBio; 2016 Jul; 7(4):. PubMed ID: 27435464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal Antibodies against Zika Virus NS1 Protein Confer Protection via Fc
    Yu L; Liu X; Ye X; Su W; Zhang X; Deng W; Luo J; Xiang M; Guo W; Zhang S; Xu W; Yan Q; Wang Q; Cui Y; Wu C; Guo W; Niu X; Zhang F; Lei C; Qu L; Chen L; Feng L
    mBio; 2021 Feb; 12(1):. PubMed ID: 33563822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Zika Virus Envelope Protein Domain III as a Target of Human Neutralizing Antibodies.
    Gallichotte EN; Young EF; Baric TJ; Yount BL; Metz SW; Begley MC; de Silva AM; Baric RS
    mBio; 2019 Sep; 10(5):. PubMed ID: 31530669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization with phage virus-like particles displaying Zika virus potential B-cell epitopes neutralizes Zika virus infection of monkey kidney cells.
    Basu R; Zhai L; Contreras A; Tumban E
    Vaccine; 2018 Feb; 36(10):1256-1264. PubMed ID: 29395533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis of a potent human monoclonal antibody against Zika virus targeting a quaternary epitope.
    Long F; Doyle M; Fernandez E; Miller AS; Klose T; Sevvana M; Bryan A; Davidson E; Doranz BJ; Kuhn RJ; Diamond MS; Crowe JE; Rossmann MG
    Proc Natl Acad Sci U S A; 2019 Jan; 116(5):1591-1596. PubMed ID: 30642974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Antigenic Site Spanning Domains I and III of the Zika Virus Envelope Glycoprotein Is the Target of Strongly Neutralizing Human Monoclonal Antibodies.
    Graham SD; Tu HA; McElvany BD; Graham NR; Grinyo A; Davidson E; Doranz BJ; Diehl SA; de Silva AM; Markmann AJ
    J Virol; 2021 Apr; 95(9):. PubMed ID: 33597214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human antibody response to Zika targets type-specific quaternary structure epitopes.
    Collins MH; Tu HA; Gimblet-Ochieng C; Liou GA; Jadi RS; Metz SW; Thomas A; McElvany BD; Davidson E; Doranz BJ; Reyes Y; Bowman NM; Becker-Dreps S; Bucardo F; Lazear HM; Diehl SA; de Silva AM
    JCI Insight; 2019 Apr; 4(8):. PubMed ID: 30996133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ZIKV Envelope Domain-Specific Antibodies: Production, Purification and Characterization.
    Akhras S; Herrlein ML; Elgner F; Holzhauser T; Hildt E
    Viruses; 2019 Aug; 11(8):. PubMed ID: 31412626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Zika virus binding and enhancement potential of a large panel of flavivirus murine monoclonal antibodies.
    Willis E; Hensley SE
    Virology; 2017 Aug; 508():1-6. PubMed ID: 28475924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of the immunogenicity of Zika glycan loop.
    Henderson EA; Tam CC; Cheng LW; Ngono AE; Nguyen AV; Shresta S; McGee M; Padgett H; Grill LK; Martchenko Shilman M
    Virol J; 2020 Mar; 17(1):43. PubMed ID: 32234060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large-scale analysis of B-cell epitopes of envelope: Implications for Zika vaccine and immunotherapeutic development.
    Almansour I; Alfares R; Aljofi H
    F1000Res; 2018; 7():1624. PubMed ID: 31316749
    [No Abstract]   [Full Text] [Related]  

  • 16. Zika Virus Envelope Protein and Antibody Complexes.
    Dai L; Wang Q; Song H; Gao GF
    Subcell Biochem; 2018; 88():147-168. PubMed ID: 29900496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural Basis of Zika Virus-Specific Antibody Protection.
    Zhao H; Fernandez E; Dowd KA; Speer SD; Platt DJ; Gorman MJ; Govero J; Nelson CA; Pierson TC; Diamond MS; Fremont DH
    Cell; 2016 Aug; 166(4):1016-1027. PubMed ID: 27475895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probing Zika Virus Neutralization Determinants with Glycoprotein Mutants Bearing Linear Epitope Insertions.
    Chambers MT; Schwarz MC; Sourisseau M; Gray ES; Evans MJ
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29976678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational Design of Zika Virus Subunit Vaccine with Enhanced Efficacy.
    Tai W; Chen J; Zhao G; Geng Q; He L; Chen Y; Zhou Y; Li F; Du L
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31189716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational Engineering and Characterization of an mAb that Neutralizes Zika Virus by Targeting a Mutationally Constrained Quaternary Epitope.
    Tharakaraman K; Watanabe S; Chan KR; Huan J; Subramanian V; Chionh YH; Raguram A; Quinlan D; McBee M; Ong EZ; Gan ES; Tan HC; Tyagi A; Bhushan S; Lescar J; Vasudevan SG; Ooi EE; Sasisekharan R
    Cell Host Microbe; 2018 May; 23(5):618-627.e6. PubMed ID: 29746833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.